Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
In a randomized, double-blind trial, BMD of the operated proximal femur after total hip
replacement measured by dual-energy x-ray absorptiometry (DXA) were compared for up to two
years in patients receiving IV ZOL 5 mg infusion (n = 27) or placebo (IV saline infusion; n =
24) at two weeks and one year after surgery.